BACKGROUND: The objective of the current study was to examine how modifiable factors such as satisfaction with cancer care and self-efficacy impact health-related quality of life (HRQOL) among Latino cancer survivors. METHODS: Latinos previously diagnosed with breast, prostate, or colorectal cancer (N = 288) completed questionnaires (Patient Satisfaction with Cancer Care Scale, Stanford Chronic Disease Self-Management Measures, Functional Assessment of Cancer Therapy-General, and Short Acculturation Scale for Hispanics) within 2 years after receiving primary cancer treatment. RESULTS: Path model analyses demonstrated that satisfaction with cancer care was associated with greater HRQOL and that this relationship was explained by several facets of self-efficacy (ie, confidence in managing psychological distress [z = 3.81; P<.001], social support from close others [z = 2.46; P = .014], social/recreational activities [z = 3.30; P = .001], and patient-provider communication [z = -3.72; P<.001]). Importantly, foreign-born, less acculturated, and monolingual Spanish-speaking survivors reported lower self-efficacy in patient-provider communication; however, adjusting for acculturation, language, nativity, and other covariates did not alter these results. CONCLUSIONS: Factors that contribute to disparities in HRQOL among Latino cancer survivors compared with non-Latino whites, such as low income, less education, and a lack of health insurance, can be difficult to address. The findings of the current study emphasize the importance of self-efficacy within the context of patient-centered cancer care practices (eg, patient inclusion in care decisions, sufficient time with provider, ready access to medical advice) and suggest that improving satisfaction with care may increase patients' confidence in managing important aspects of their cancer experience and, in turn, improve HRQOL among Latino cancer survivors. Cancer 2018.
BACKGROUND: The objective of the current study was to examine how modifiable factors such as satisfaction with cancer care and self-efficacy impact health-related quality of life (HRQOL) among Latino cancer survivors. METHODS: Latinos previously diagnosed with breast, prostate, or colorectal cancer (N = 288) completed questionnaires (Patient Satisfaction with Cancer Care Scale, Stanford Chronic Disease Self-Management Measures, Functional Assessment of Cancer Therapy-General, and Short Acculturation Scale for Hispanics) within 2 years after receiving primary cancer treatment. RESULTS: Path model analyses demonstrated that satisfaction with cancer care was associated with greater HRQOL and that this relationship was explained by several facets of self-efficacy (ie, confidence in managing psychological distress [z = 3.81; P<.001], social support from close others [z = 2.46; P = .014], social/recreational activities [z = 3.30; P = .001], and patient-provider communication [z = -3.72; P<.001]). Importantly, foreign-born, less acculturated, and monolingual Spanish-speaking survivors reported lower self-efficacy in patient-provider communication; however, adjusting for acculturation, language, nativity, and other covariates did not alter these results. CONCLUSIONS: Factors that contribute to disparities in HRQOL among Latino cancer survivors compared with non-Latino whites, such as low income, less education, and a lack of health insurance, can be difficult to address. The findings of the current study emphasize the importance of self-efficacy within the context of patient-centered cancer care practices (eg, patient inclusion in care decisions, sufficient time with provider, ready access to medical advice) and suggest that improving satisfaction with care may increase patients' confidence in managing important aspects of their cancer experience and, in turn, improve HRQOL among Latino cancer survivors. Cancer 2018.
Authors: Pascal Jean-Pierre; Kevin Fiscella; Karen M Freund; Jack Clark; Julie Darnell; Alan Holden; Douglas Post; Steven R Patierno; Paul C Winters Journal: Cancer Date: 2010-10-04 Impact factor: 6.860
Authors: Tim Luckett; David Goldstein; Phyllis N Butow; Val Gebski; Lynley J Aldridge; Joshua McGrane; Weng Ng; Madeleine T King Journal: Lancet Oncol Date: 2011-10-11 Impact factor: 41.316
Authors: Sarah T Hawley; Nancy K Janz; Ann Hamilton; Jennifer J Griggs; Amy K Alderman; Mahasin Mujahid; Steven J Katz Journal: Patient Educ Couns Date: 2008-11
Authors: Charles J Rosser; Deborah A Kuban; Lawrence B Levy; Curtis A Pettaway; Ramsey Chichakli; Ashish M Kamat; Ricardo F Sanchez-Ortiz; Louis L Pisters Journal: J Urol Date: 2003-11 Impact factor: 7.450
Authors: Richard M Hoffman; William C Hunt; Frank D Gilliland; Robert A Stephenson; Arnold L Potosky Journal: Cancer Date: 2003-04-01 Impact factor: 6.860
Authors: Margaret A Chesney; Donald B Chambers; Jonelle M Taylor; Lisa M Johnson; Susan Folkman Journal: Psychosom Med Date: 2003 Nov-Dec Impact factor: 4.312
Authors: Jean A McDougall; Cindy K Blair; Charles L Wiggins; Michael B Goodwin; Vi K Chiu; Ashwani Rajput; Anita Y Kinney Journal: J Cancer Surviv Date: 2019-05-20 Impact factor: 4.442
Authors: Patricia I Moreno; Amelie G Ramirez; Sandra L San Miguel-Majors; Leopoldo Castillo; Rina S Fox; Kipling J Gallion; Edgar Munoz; Ryne Estabrook; Arely Perez; Thomas Lad; Courtney Hollowell; Frank J Penedo Journal: Support Care Cancer Date: 2018-08-22 Impact factor: 3.603
Authors: Steven S Coughlin; Valerie Williams; Nicole Moore; Deborah Bowen; Judith Anglin; Nadine Mansur; Gianluca De Leo Journal: J Cancer Treatment Diagn Date: 2018-06-06
Authors: Carol Y Ochoa; Kimberly A Miller; Lourdes Baezconde-Garbanati; Rhona I Slaughter; Ann S Hamilton; Joel E Milam Journal: J Health Commun Date: 2021-03-10
Authors: Eunjeong Ko; María Luisa Zúñiga; Susan I Woodruff; Yolanda Serra-Martinez; Veronica Cardenas Journal: Int J Environ Res Public Health Date: 2020-08-10 Impact factor: 3.390